"Orlickoústecká nemocnice je součástí společnosti Nemocnice Pardubického kraje, a. s. Ta se s ročním obratem více než 3,5 miliardy korun a zhruba 4 600 zaměstnanci řadí mezi desítku největších nemocnic v zemi. Společnost tvoří pět pracovišť: • Pardubická nemocnice • Chrudimská nemocnice • Orlickoústecká nemocnice • Litomyšlská nemocnice • Svitavská nemocnice"

During the past decade, Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice" #1 sponsor was "Shire" with 3 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Norgine" with 1 trials sponsored and "sigma-tau i.f.r. S.p.A." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice" are "Ulcerative Colitis" (4 trials), "Constipation" (1 trials), "Crohn's Disease" (1 trials), "Diabetic Nephropathies" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice" in a lesser frequency.

Most popular intervention types in "Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ontamalimab" (2 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "MOVICOL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".